Comparison of Three Diagnostic Frameworks for Pyoderma Gangrenosum.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
01 2021
Historique:
received: 16 01 2020
revised: 14 04 2020
accepted: 29 04 2020
pubmed: 24 5 2020
medline: 7 9 2021
entrez: 24 5 2020
Statut: ppublish

Résumé

Pyoderma gangrenosum (PG) is an inflammatory condition characterized by chronic cutaneous ulcerations. There are three proposed PG diagnostic frameworks (Su, PARACELSUS, Delphi); however, they lack consensus, and their performance has not yet been validated in a well-defined cohort of patients with PG. In this cross-sectional retrospective cohort study, we sought to evaluate and compare the concordance of these diagnostic frameworks within a single-institution cohort of patients with PG. There were 47 patients from an initial 76 identified by International Classification of Diseases-9 and/or International Classification of Diseases-10 codes, where two PG experts agreed in their diagnosis of PG on the basis of clinical descriptions, photographs, and pathology. This group was the PG cohort by which we evaluated the performance and concordance of the diagnostic frameworks. The PARACELSUS score identified the highest proportion of patients with PG (89% [42 of 47 patients]), followed by Delphi and Su criteria, each at 74% (35 of 47 patients). Assessment of multirater agreement found that the three criteria agreed in their diagnoses for 72% of the patients (95% confidence interval = 60-85%); chance-adjusted agreement was determined to be 0.44 (95% confidence = 0.16-0.68, Fleiss' kappa). Future research should seek to refine these diagnostic frameworks and identify targeted methods of testing to reduce rates of PG misdiagnosis and patient misclassification in clinical trials.

Identifiants

pubmed: 32445742
pii: S0022-202X(20)31583-9
doi: 10.1016/j.jid.2020.04.019
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-63

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Carter Haag (C)

Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.

Trevor Hansen (T)

Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia, USA.

Tamar Hajar (T)

Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.

Emile Latour (E)

Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

Jesse Keller (J)

Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.

Kanade Shinkai (K)

Department of Dermatology, University of California San Francisco, San Francisco, California, USA.

Alex G Ortega-Loayza (AG)

Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA. Electronic address: ortegalo@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH